Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)

✍ Scribed by Peter A. LeWitt; M. Guttman; James W. Tetrud; Paul J. Tuite; Akihisa Mori; Philip Chaikin; Neil M. Sussman

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 146 KB
• Volume: 63
• Category: Article
• ISSN: 0364-5134
• DOI: 10.1002/ana.21315